Academic Journals Database
Disseminating quality controlled scientific knowledge

Resolution of Chronic Subdural Hematoma after Treatment with Tumor Necrosis Factor Alpha Inhibitor

ADD TO MY LIST
 
Author(s): Donald Ross

Journal: Neuroscience & Medicine
ISSN 2158-2912

Volume: 02;
Issue: 04;
Start page: 347;
Date: 2011;
Original page

Keywords: Chronic Subdural Hematoma | Tumor Necrosis Factor Alpha | Inflammation

ABSTRACT
Background and Importance: Chronic subdural hematomas (cSDH) are a common problem for which solutions remain imperfect. Surgery is effective, but not without risk. Recent data have suggested a role for inflammation in the genesis of cSDH and several reports have documented some benefit to steroid treatment. In this report, a possible role for tumor necrosis factor alpha blockade in the resolution of a multiply recurrent cSDH is described. Clinical Presentation: An 86-year-old man with rheumatoid arthritis treated with infliximab presented with a large, symptomatic, multiloculated cSDH. Infliximab was withheld and craniotomy for evacuation was uncomplicated, but recurrent symptoms were noted and a recurrence was operated upon again several weeks later. Follow up CT showed a second recurrence. The patient requested to go back on his infliximab due to painful arthralgias. After a single dose of 10 mg/kg, follow up CT showed that the cSDH resolved and did not recur. Conclusion: Anti-TNF-alpha treatment with infliximab may have played a role in the resolution of this patient’s cSDH. Further investigation of this possible effect seems warranted.
Save time & money - Smart Internet Solutions     

Tango Rapperswil
Tango Rapperswil